TEVA

Teva Pharmaceutical Industries
TEVA

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$16.39B
EV
$31.62B
Shares Outstanding
1.15B
Beta
0.72

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$22.88
P/E 2025E
5.58x
P/Revenue 2025E
0.95x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Teva Pharmaceutical Industries Limited

gainify
TEVA

Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, s...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Francis, Richard

Employees

34,789

IPO Date

1982-02-16

Headquarters

124 Dvora HaNevi’a Street, Tel Aviv 6944020, Israel

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved